The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
IDEAYA Biosciences, Inc(NASDAQ:IDYA) 
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is...
Website: http://www.ideayabio.com
Founded: 2015
IPO Price: $10 (May 23, 2019)
Full Time Employees: 58
CEO: Yujiro S. Hata
Sector: Healthcare
Industry: Biotechnology
IDEAYA Biosciences Days Payable Outstanding ttm (DPO)
IDEAYA Biosciences Days Receivable Outstanding ttm (DSO)
IDEAYA Biosciences Days Inventory Outstanding ttm (DIO)
IDEAYA Biosciences Op Cashflow Per Share ttm
IDEAYA Biosciences Free Cashflow Per Share ttm
IDEAYA Biosciences Cash Per Share ttm
IDEAYA Biosciences P/S ratio ttm
IDEAYA Biosciences (GAAP) P/E ratio ttm
IDEAYA Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.